Therapeutic potential of anti-inflammatory drugs in focal stroke
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The importance of cytokines, especially TNF-alpha and IL-1beta, are emphasised in the propagation and maintenance of the brain inflammatory response to injury. Much data supports the case that ischaemia and trauma elicit an inflammatory response in the injured brain. This inflammatory response consists of mediators (cytokines, chemokines and adhesion molecules) followed by cells (neutrophils early after the onset of brain injury and then a later monocyte infiltration). De novo upregulation of pro-inflammatory cytokines, chemokines and endothelial-leukocyte adhesion molecules occurs soon after focal ischaemia and trauma, as well as at the time when the tissue injury is evolving. The significance of this brain inflammatory response and its contribution to brain injury is now becoming more understood. In this review, we discuss the role of TNF-alpha and IL-1beta in traumatic and ischaemic brain injury and associated inflammation and the co-operative actions of chemokines and adhesion molecules in this process. We also address novel approaches to target cytokines and reduce the brain inflammatory response and thus brain injury, in stroke and neurotrauma. The mitogen-activated protein kinase (MAPK), p38, has been linked to inflammatory cytokine production and cell death following cellular stress. Stroke-induced p38 enzyme activation in the brain has been demonstrated and treatment with a second generation p38 MAPK inhibitor, SB-239063, provides a significant reduction in infarct size, neurological deficits and inflammatory cytokine expression produced by focal stroke. SB-239063 can also provide direct protection of cultured brain tissue to in vitro ischaemia. This robust SB-239063-induced neuroprotection emphasises a significant opportunity for targeting MAPK pathways in ischaemic stroke injury and also suggests that p38 inhibition should be evaluated for protective effects in other experimental models of nervous system injury and neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor necrosis factor: a pleiotropic cytokine and therapuetic target
Tracey, M. D., & Cerami, P. D. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.491 · Cited by 1,063
Tumor Necrosis Factor-α: A Mediator of Focal Ischemic Brain Injury
Barone, F. C., Arvin, B., White, R. F., Miller, A., Webb, C. L., Willette, R. N., Lysko, P. G., & Feuerstein, G. Z. (1997) · Stroke · doi:10.1161/01.str.28.6.1233 · Cited by 863
Self-citationInterleukin 1 of the central nervous system is produced by ameboid microglia.
Giulian, D., Baker, T. J., Shih, L. C., & Lachman, L. B. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.2.594 · Cited by 859 · cited 1×
“Since cytokines activate glial cells in vivo [15] and glial cells produce cytokines in response to stimulation in vitro [20-22], a close relationship would appear to exist between inflammation, cytokine production and gliosis.”
BackgroundMalfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160105897 · Cited by 669
Matsuo, Y., Onodera, H., Shiga, Y., Nakamura, M., Ninomiya, M., Kihara, T., & Kogure, K. (1994) · Stroke · doi:10.1161/01.str.25.7.1469 · Cited by 485 · cited 1×
“have used the RP-3 mAb that selectively depletes leukocytes in the rat (about 90 - 95%) and reported a dramatic reduction in both neutrophil accumulation in focal ischaemic brain tissue and infarct size (decreased by 45 - 50%) [157].”
Methodp38 Kinase Is Activated in the Alzheimer's Disease Brain
Hensley, K., Floyd, R. A., Zheng, N., Nael, R., Robinson, K. A., Nguyen, X., Pye, Q. N., Stewart, C. A., Geddes, J., Markesbery, W. R., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722053.x · Cited by 373 · cited 1×
“This approach should be extended in the future by evaluating p38 inhibition in other models of CNS injury, including cerebral haemorrhage, traumatic brain and spinal injury [42,220] and neurodegenerative diseases [221].”
BackgroundReactive astrogliosis in the neonatal mouse brain and its modulation by cytokines
Balasingam, V, Tejada-Berges, T., Wright, E., Bouckova, R., & Yong, V. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-02-00846.1994 · Cited by 342 · cited 2×
“Indeed, elegant experiments have shown that gliosis can be induced by TNF-α, IL-1β and IFN-α [23,24].”
BackgroundBrain interleukin 1 gene expression induced by peripheral lipopolysaccharide administration
BAN, E. (1992) · Cytokine · doi:10.1016/1043-4666(92)90036-q · Cited by 220
Cited by
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Overview of cell death signaling pathways
Jin, Z., & El-Deiry, W. S. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.2.1508 · Cited by 1,326
Inflammatory response in acute traumatic brain injury: a double-edged sword
Morganti-Kossmann, M. C., Rancan, M., Stahel, P. F., & Kossmann, T. (2002) · Current Opinion in Critical Care · doi:10.1097/00075198-200204000-00002 · Cited by 681
Treatment of neural injury with marrow stromal cells
Chopp, M., & Li, Y. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00040-6 · Cited by 624
Deb, P., Sharma, S., & Hassan, K. M. (2010) · Pathophysiology · doi:10.1016/j.pathophys.2009.12.001 · Cited by 562
Krams, M., Lees, K. R., Hacke, W., Grieve, A. P., Orgogozo, J.-M., & Ford, G. A. (2003) · Stroke · doi:10.1161/01.str.0000092527.33910.89 · Cited by 430
Green, A. R. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707594 · Cited by 177
“…the tumour necrosis factor (TNF)a and IL-1b (Figure 2), are the major factors involved in the inflammatory response of the brain to injury (Barone and Parsons, 2000; Allan and Rothwell, 2001), and both TNFa antibodies (Barone et al., 1997) and IL-1b antibodies (Relton and Rothwell, 1992)…”
BackgroundYarahmadi, A., Dorri Giv, M., Hosseininejad, R., Rezaie, A., Mohammadi, N., Afkhami, H., & Farokhi, A. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1472679 · Cited by 21
Sheu, J.-N., Liao, W.-C., Wu, U.-I., Shyu, L.-Y., Mai, F.-D., Chen, L.-Y., Chen, M.-J., Youn, S.-C., & Chang, H.-M. (2013) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2012.11.002 · Cited by 20
Metadata
- Authors
- Barone, F. C., & Parsons, A. A.
- Venue
- Expert Opinion on Investigational Drugs
- Publisher
- Informa UK Limited
- Published
- 2000-10
- Volume
- 9
- Issue
- 10
- Pages
- 2281-2306
- ISSN
- 1354-3784 (ISSN-L)
- 1744-7658
- OpenAlex
- W2158709261
- Cited by
- 81
- References
- 8
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.